Showing results (701-710 of 730) with videos related to

Sort By:
Pageof 73
The Journal of Investigative Dermatology|September 17, 2023
Type 2 T-Cell Responses against Distinct Epitopes of the Desmoglein 3 Ectodomain in Pemphigus VulgarisDario Didona, Luca Scarsella, Christoph Hudemann, et al.
BMJ Open|October 31, 2022
Minimally invasivE versus open total GAstrectomy (MEGA): study protocol for a multicentre randomised controlled trial (DRKS00025765)Felix Nickel, Alexander Studier-Fischer, David Hausmann, et al.
JAMA Neurology|March 10, 2015
Mutation in CPT1C Associated With Pure Autosomal Dominant Spastic ParaplegiaCarlo Rinaldi, Thomas Schmidt, Alan J Situ, et al.
Molecular Cancer|January 10, 2024
Stratifying esophago-gastric cancer treatment using a patient-derived organoid-based thresholdTim Schmäche, Juliane Fohgrub, Anna Klimova, et al.
Cancer Cell|June 14, 2011
Loss or inhibition of stromal-derived PlGF prolongs survival of mice with imatinib-resistant Bcr-Abl1(+) leukemiaThomas Schmidt, Behzad Kharabi Masouleh, Sonja Loges, et al.
Annals of Surgery|August 7, 2024
Optimal Treatment Strategies for cT2 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A Multinational, High-volume Center Retrospective Cohort AnalysisNaita M Wirsik, Cezanne D Kooij, Niall Dempster, et al.
Annals of Surgical Oncology|October 14, 2025
Comparison of Pretreatment Strategies for cT2cN0 Staged Adenocarcinoma of the Esophagus and the Gastroesophageal Junction: A European High-Volume Center Cohort AnalysisNaita M Wirsik, Thomas Schmidt, Cezanne D Kooij, et al.
Oncoimmunology|July 3, 2015
Anti-angiogenic activity of VXM01, an oral T-cell vaccine against VEGF receptor 2, in patients with advanced pancreatic cancer: A randomized, placebo-controlled, phase 1 trialFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Andreas G Niethammer, et al.
Nature Communications|August 21, 2023
An X-ray free-electron laser with a highly configurable undulator and integrated chicanes for tailored pulse propertiesEduard Prat, Andre Al Haddad, Christopher Arrell, et al.
Nature|July 1, 2026
TROP2 targeting reveals therapy-driven cell state dynamics in colorectal cancerNuria Vaquero-Siguero, Nikolaos Georgakopoulos, Maria C Puschhof, et al.
Pageof 73